Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, December 04, 2015 12:20:51 PM
bullish 15.85
## source: finance.yahoo.com
Thu, 03 Dec 2015 16:04:18 GMT ~ Nektar Therapeutics Earnings Q3, 2015
read full: http://www.capitalcube.com/blog/index.php/nektar-therapeutics-earnings-q3-2015/
*********************************************************
Mon, 30 Nov 2015 15:21:00 GMT ~ Baxalta Announces U.S. Availability of ADYNOVATE, A New Treatment for Adult Patients with Hemophilia A With a Simple, Twice-Weekly Dosing Schedule
[PR Newswire] - BANNOCKBURN, Ill., Nov. 30, 2015 /PRNewswire/ -- Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and ...
read full: http://finance.yahoo.com/news/baxalta-announces-u-availability-adynovate-152100847.html
*********************************************************
Wed, 25 Nov 2015 13:16:34 GMT ~ Hedge Funds Aren’t Crazy About Nektar Therapeutics (NKTR) Anymore
read full: http://www.insidermonkey.com/blog/hedge-funds-arent-crazy-about-nektar-therapeutics-nktr-anymore-388609/
*********************************************************
Tue, 17 Nov 2015 21:31:00 GMT ~ Get Ready for Nektar Therapeutics (NKTR) Stock to Break Out
read full: http://www.thestreet.com/story/13369571/1/get-ready-for-nektar-nktr-stock-to-break-out.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Tue, 17 Nov 2015 21:01:00 GMT ~ Why Nektar Therapeutics Skyrocketed 30% Higher in October
read full: http://www.fool.com/investing/general/2015/11/17/why-nektar-therapeutics-skyrocketed-30-higher-in-o.aspx?source=eogyholnk0000001&utm_source=yahoo&utm_medium=feed&utm_campaign=article
*********************************************************
$NKTR charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$NKTR company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NKTR/company-info
Ticker: $NKTR
OTC Market Place: Not Available
CIK code: 0000906709
Company name: Nektar Therapeutics
Company website: http://www.nektar.com
Incorporated In: DE, USA
$NKTR share structure
## source: otcmarkets.com
Market Value: $2,029,795,368 a/o Dec 03, 2015
Shares Outstanding: 133,451,372 a/o Oct 29, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$NKTR extra dd links
Company name: Nektar Therapeutics
Company website: http://www.nektar.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NKTR+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NKTR+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NKTR+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NKTR/news - http://finance.yahoo.com/q/h?s=NKTR+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NKTR/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NKTR/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NKTR+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NKTR
DTCC (dtcc.com): http://search2.dtcc.com/?q=Nektar+Therapeutics&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Nektar+Therapeutics
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Nektar+Therapeutics&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.nektar.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.nektar.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.nektar.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NKTR
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000906709&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NKTR/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NKTR/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NKTR&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NKTR
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NKTR/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NKTR+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NKTR+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NKTR
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NKTR
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NKTR+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NKTR/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NKTR+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NKTR.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NKTR
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NKTR/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NKTR/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NKTR
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NKTR
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NKTR:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NKTR
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NKTR
$NKTR DD Notes ~ http://www.ddnotesmaker.com/NKTR
Recent NKTR News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:20:50 PM
- Nektar Therapeutics Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:15:00 PM
- Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets • PR Newswire (US) • 05/02/2024 10:00:00 PM
- Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference • PR Newswire (US) • 03/22/2024 06:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:11:03 PM
- Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata • PR Newswire (US) • 03/05/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:20:46 PM
- Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results • PR Newswire (US) • 03/04/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 01:40:59 PM
- Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX • PR Newswire (US) • 03/04/2024 01:30:00 PM
- Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference • PR Newswire (US) • 02/27/2024 11:00:00 PM
- Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets • PR Newswire (US) • 02/26/2024 11:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 01:19:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 01:17:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 01:16:48 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 08:55:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 08:51:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 08:50:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:16:10 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 10:03:19 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:50:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:25:25 PM
- Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA • PR Newswire (US) • 01/03/2024 11:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:07:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:05:59 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM